Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C T Esmon

Showing results (121-130 of 246) with videos related to

Pageof 25
Sort By:
The Journal of Biological Chemistry|April 5, 1992
The role of calcium ions in factor X activation by thrombin E192QB F Le Bonniec, E R Guinto, C T Esmon
Blood|February 1, 1986
An abnormal plasma distribution of protein S occurs in functional protein S deficiencyP C Comp, D Doray, D Patton, et al.
The Journal of Clinical Investigation|February 1, 1986
Relationship between protein C antigen and anticoagulant activity during oral anticoagulation and in selected disease statesS Vigano D'Angelo, P C Comp, C T Esmon, et al.
The Journal of Clinical Investigation|July 15, 1997
Identification of functional endothelial protein C receptor in human plasmaS Kurosawa, D J Stearns-Kurosawa, N Hidari, et al.
Journal of Thrombosis and Haemostasis : JTH|July 30, 2014
Histones induce phosphatidylserine exposure and a procoagulant phenotype in human red blood cellsF Semeraro, C T Ammollo, N L Esmon, et al.
The Journal of Clinical Investigation|May 1, 1988
Acquired deficiencies of protein S. Protein S activity during oral anticoagulation, in liver disease, and in disseminated intravascular coagulationA D'Angelo, S Vigano-D'Angelo, C T Esmon, et al.
The Journal of Biological Chemistry|January 15, 1986
Cultured bovine aortic endothelial cells promote activated protein C-protein S-mediated inactivation of factor VaD M Stern, P P Nawroth, K Harris, et al.
Haematologica|May 18, 1999
Lupus anticoagulants, thrombosis and the protein C systemN L Esmon, M D Smirnov, O Safa, et al.
Biochemistry|February 23, 1999
Factor VIIa/tissue factor generates a form of factor V with unchanged specific activity, resistance to activation by thrombin, and increased sensitivity to activated protein CO Safa, J H Morrissey, C T Esmon, et al.
Journal of Autoimmunity|September 2, 2000
Antiphospholipid antibodies and the protein C pathwayN L Esmon, O Safa, M D Smirnov, et al.
Pageof 25

Showing results (121-130 of 246) with videos related to

Sort By:
Pageof 25
The Journal of Biological Chemistry|April 5, 1992
The role of calcium ions in factor X activation by thrombin E192QB F Le Bonniec, E R Guinto, C T Esmon
Blood|February 1, 1986
An abnormal plasma distribution of protein S occurs in functional protein S deficiencyP C Comp, D Doray, D Patton, et al.
The Journal of Clinical Investigation|February 1, 1986
Relationship between protein C antigen and anticoagulant activity during oral anticoagulation and in selected disease statesS Vigano D'Angelo, P C Comp, C T Esmon, et al.
The Journal of Clinical Investigation|July 15, 1997
Identification of functional endothelial protein C receptor in human plasmaS Kurosawa, D J Stearns-Kurosawa, N Hidari, et al.
Journal of Thrombosis and Haemostasis : JTH|July 30, 2014
Histones induce phosphatidylserine exposure and a procoagulant phenotype in human red blood cellsF Semeraro, C T Ammollo, N L Esmon, et al.
The Journal of Clinical Investigation|May 1, 1988
Acquired deficiencies of protein S. Protein S activity during oral anticoagulation, in liver disease, and in disseminated intravascular coagulationA D'Angelo, S Vigano-D'Angelo, C T Esmon, et al.
The Journal of Biological Chemistry|January 15, 1986
Cultured bovine aortic endothelial cells promote activated protein C-protein S-mediated inactivation of factor VaD M Stern, P P Nawroth, K Harris, et al.
Haematologica|May 18, 1999
Lupus anticoagulants, thrombosis and the protein C systemN L Esmon, M D Smirnov, O Safa, et al.
Biochemistry|February 23, 1999
Factor VIIa/tissue factor generates a form of factor V with unchanged specific activity, resistance to activation by thrombin, and increased sensitivity to activated protein CO Safa, J H Morrissey, C T Esmon, et al.
Journal of Autoimmunity|September 2, 2000
Antiphospholipid antibodies and the protein C pathwayN L Esmon, O Safa, M D Smirnov, et al.
Pageof 25